Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Knowing what to include in a retirement plan at 50 is key to success. Prepare a robust financial strategy for your future.
21,538 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
DeFi is at a crossroads: grow or endure risk. Experts propose a defended capital metric to measure true resilience be...
The European Union and Mercosur clinched a landmark free-trade agreement after 25 years of negotiations, linking 700 ...
Analysts see a wall street pros upside for Royal Caribbean as 2026 capacity and earnings guidance point to a stronger...
SanDisk announced a $1 billion strategic equity investment in Nanya Technology, prompting a roughly 6% share decline ...
A fresh rally in semiconductor names has investors buzzing about CPU pricing power and AI infrastructure demand. This...
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
Red Cat Holdings posted a record Q4 revenue of $26.2 million and full-year $40.7 million, but margins stayed thin and...
A Pantera report shows most tokenized assets sit as wrappers rather than native on-chain instruments, signaling a cau...
European defense funding is moving to multi-year commitments, reshaping orders for European and U.S. defense contract...
Analysts released a fresh batch of top calls on Thursday, reshaping sentiment across industrials and tech as earnings...
States expand aid to middle-income buyers as mortgage costs and home prices stay elevated. The shift broadens access ...